EE200200216A - Aromaatsed diketoderivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon - Google Patents

Aromaatsed diketoderivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon

Info

Publication number
EE200200216A
EE200200216A EEP200200216A EEP200200216A EE200200216A EE 200200216 A EE200200216 A EE 200200216A EE P200200216 A EEP200200216 A EE P200200216A EE P200200216 A EEP200200216 A EE P200200216A EE 200200216 A EE200200216 A EE 200200216A
Authority
EE
Estonia
Prior art keywords
diketoderivatives
aromatic
processes
preparation
pharmaceutical composition
Prior art date
Application number
EEP200200216A
Other languages
English (en)
Estonian (et)
Inventor
V�rtesy L�szl�
Kurz Michael
Paulus Erich
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200216A publication Critical patent/EE200200216A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EEP200200216A 1999-10-25 2000-08-19 Aromaatsed diketoderivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon EE200200216A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99121241 1999-10-25
PCT/EP2000/008103 WO2001030736A2 (en) 1999-10-25 2000-08-19 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors

Publications (1)

Publication Number Publication Date
EE200200216A true EE200200216A (et) 2003-06-16

Family

ID=8239274

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200216A EE200200216A (et) 1999-10-25 2000-08-19 Aromaatsed diketoderivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon

Country Status (24)

Country Link
US (1) US6380257B1 (cs)
EP (1) EP1248763B1 (cs)
JP (1) JP2003512448A (cs)
KR (1) KR100755730B1 (cs)
CN (1) CN1192999C (cs)
AR (1) AR034095A1 (cs)
AU (1) AU779352B2 (cs)
BR (1) BR0015023A (cs)
CA (1) CA2388957C (cs)
CZ (1) CZ20021404A3 (cs)
EE (1) EE200200216A (cs)
HK (1) HK1049827B (cs)
HR (1) HRP20020352A2 (cs)
HU (1) HUP0203129A3 (cs)
IL (1) IL149156A0 (cs)
NO (1) NO20021812L (cs)
NZ (1) NZ518545A (cs)
PL (1) PL205217B1 (cs)
RS (1) RS50431B (cs)
RU (1) RU2252211C2 (cs)
SK (1) SK287428B6 (cs)
TR (1) TR200201124T2 (cs)
WO (1) WO2001030736A2 (cs)
ZA (1) ZA200203034B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10208828A1 (de) * 2002-03-01 2003-09-11 Bayer Ag Verfahren zur Reduktion von 3-Heteroaryl-3-oxopropionsäurederivaten
KR101106152B1 (ko) * 2010-05-14 2012-01-20 (주)한국킹유전자 주야 변환형 사인보드
WO2020257100A1 (en) 2019-06-20 2020-12-24 Exxonmobil Chemical Patents Inc. Branched alcohols formed from vinylidene olefins by hydroformylation and methods for production therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW399041B (en) 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (cs) * 1992-09-09 1995-09-01 Hoechst Ag
EP0912244A4 (en) 1996-07-15 2001-09-12 Mobil Oil Corp COMIMONED BIMETALLIC CATALYST FOR BLOW MOLDING AND FILMS
AR012449A1 (es) * 1997-04-18 2000-10-18 Hoechst Marion Roussell Deutschland Gmbh Kodaistatinas a, b, c y d, proceso para su produccion, y su uso.
DE19740080A1 (de) * 1997-09-12 1999-03-18 Hoechst Marion Roussel De Gmbh Neue Phthalaldehyd-Derivate, Verfahren zu deren Herstellung und deren Verwendung
CN1306580A (zh) * 1998-06-24 2001-08-01 阿文蒂斯药物德国有限公司 木白斯他汀、其制备方法以及作为药物的应用

Also Published As

Publication number Publication date
RS50431B (sr) 2009-12-31
ZA200203034B (en) 2002-11-21
HRP20020352A2 (en) 2004-02-29
CA2388957A1 (en) 2001-05-03
NZ518545A (en) 2004-07-30
NO20021812L (no) 2002-05-14
YU27002A (sh) 2005-06-10
HUP0203129A2 (hu) 2003-01-28
SK5442002A3 (en) 2002-12-03
RU2252211C2 (ru) 2005-05-20
CN1192999C (zh) 2005-03-16
WO2001030736A3 (en) 2001-11-01
KR20020047262A (ko) 2002-06-21
SK287428B6 (sk) 2010-09-07
KR100755730B1 (ko) 2007-09-06
CN1379752A (zh) 2002-11-13
US6380257B1 (en) 2002-04-30
EP1248763B1 (en) 2014-06-25
WO2001030736A2 (en) 2001-05-03
AU779352B2 (en) 2005-01-20
CA2388957C (en) 2009-01-06
HK1049827A1 (en) 2003-05-30
AR034095A1 (es) 2004-02-04
TR200201124T2 (tr) 2002-09-23
PL205217B1 (pl) 2010-03-31
AU7278200A (en) 2001-05-08
EP1248763A2 (en) 2002-10-16
IL149156A0 (en) 2002-11-10
CZ20021404A3 (cs) 2002-07-17
HK1049827B (zh) 2005-09-02
JP2003512448A (ja) 2003-04-02
NO20021812D0 (no) 2002-04-17
PL354452A1 (en) 2004-01-12
HUP0203129A3 (en) 2003-12-29
BR0015023A (pt) 2002-06-18

Similar Documents

Publication Publication Date Title
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
NO20016038D0 (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
EE04527B1 (et) Aromaatsed heterotsüklilised ühendid, nende kasutamine ja meetodid nende valmistamiseks
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
FI991485A0 (fi) Uusi farmaseuttinen koostumus
EE04915B1 (et) Kinuklidiinderivaadid, nende valmistamismeetod, vahehendid, farmatseutiline kompositsioon ja nende kasutamine
NO20015175L (no) Farmasöytisk sammensetning
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
EE200000651A (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE200100209A (et) Tritsüklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
FI4488U1 (fi) Farmaseuttinen koostumus
EE200100210A (et) Tritsüklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE200100544A (et) 15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon